Literature DB >> 25363526

PD-1 induction through TCR activation is partially regulated by endogenous TGF-β.

Raja Rekik1, Nadia Belhadj Hmida1, Ahlem Ben Hmid2,3, Imen Zamali2, Ns Kammoun2, Melika Ben Ahmed1,2,3.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25363526      PMCID： PMC4579643          DOI： 10.1038/cmi.2014.104

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  10 in total

1.  Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus.

Authors:  Helga Kristjansdottir; Kristjan Steinsson; Iva Gunnarsson; Gerdur Gröndal; Kristjan Erlendsson; Marta E Alarcón-Riquelme
Journal:  Arthritis Rheum       Date:  2010-06

Review 2.  The B7 family revisited.

Authors:  Rebecca J Greenwald; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice.

Authors:  Shimpei Kasagi; Seiji Kawano; Taku Okazaki; Tasuku Honjo; Akio Morinobu; Saori Hatachi; Kenichiro Shimatani; Yoshimasa Tanaka; Nagahiro Minato; Shunichi Kumagai
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

4.  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.

Authors:  Ludmila Prokunina; Casimiro Castillejo-López; Fredrik Oberg; Iva Gunnarsson; Louise Berg; Veronica Magnusson; Anthony J Brookes; Dmitry Tentler; Helga Kristjansdóttir; Gerdur Gröndal; Anne Isine Bolstad; Elisabet Svenungsson; Ingrid Lundberg; Gunnar Sturfelt; Andreas Jönssen; Lennart Truedsson; Guadalupe Lima; Jorge Alcocer-Varela; Roland Jonsson; Ulf B Gyllensten; John B Harley; Donato Alarcón-Segovia; Kristján Steinsson; Marta E Alarcón-Riquelme
Journal:  Nat Genet       Date:  2002-10-28       Impact factor: 38.330

5.  Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF.

Authors:  Susumu Nakae; Hajime Suto; Motoyasu Iikura; Maki Kakurai; Jonathon D Sedgwick; Mindy Tsai; Stephen J Galli
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

6.  Resistance to exogenous TGF-β effects in patients with systemic lupus erythematosus.

Authors:  Asma Elbeldi-Ferchiou; Mélika Ben Ahmed; Monia Smiti-Khanfir; Mohamed Habib Houman; Maha Abdeladhim; Nadia Belhadj Hmida; Nadine Cerf-Bensussan; Hechmi Louzir
Journal:  J Clin Immunol       Date:  2011-04-19       Impact factor: 8.317

7.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

Authors:  H Nishimura; M Nose; H Hiai; N Minato; T Honjo
Journal:  Immunity       Date:  1999-08       Impact factor: 31.745

8.  Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer.

Authors:  Yan Zhang; Shengdong Huang; Dejun Gong; Yanghua Qin; Qian Shen
Journal:  Cell Mol Immunol       Date:  2010-05-31       Impact factor: 11.530

9.  Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects.

Authors:  Isabel Ferreiros-Vidal; Juan J Gomez-Reino; Francisco Barros; Angel Carracedo; Patricia Carreira; Francisca Gonzalez-Escribano; Myriam Liz; Javier Martin; Josep Ordi; Jose L Vicario; Antonio Gonzalez
Journal:  Arthritis Rheum       Date:  2004-08

10.  Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

Authors:  Manish J Butte; Mary E Keir; Theresa B Phamduy; Arlene H Sharpe; Gordon J Freeman
Journal:  Immunity       Date:  2007-07-12       Impact factor: 31.745
  10 in total
  12 in total

1.  Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy.

Authors:  Masaki Terabe; Faith C Robertson; Katharine Clark; Emma De Ravin; Anja Bloom; David J Venzon; Shingo Kato; Amer Mirza; Jay A Berzofsky
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

Review 2.  Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors.

Authors:  Tatsuki Ueda; Shin Kaneko
Journal:  Int J Hematol       Date:  2020-07-23       Impact factor: 2.490

3.  Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ.

Authors:  Amy E Moran; Fanny Polesso; Andrew D Weinberg
Journal:  J Immunol       Date:  2016-08-08       Impact factor: 5.422

Review 4.  Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.

Authors:  Yuan Hu; Zhi-Gang Tian; Cai Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-09-07       Impact factor: 6.150

5.  High activation and skewed T cell differentiation are associated with low IL-17A levels in a hu-PBL-NSG-SGM3 mouse model of HIV infection.

Authors:  F Perdomo-Celis; S Medina-Moreno; H Davis; J Bryant; N A Taborda; M T Rugeles; S Kottilil; J C Zapata
Journal:  Clin Exp Immunol       Date:  2020-01-21       Impact factor: 4.330

Review 6.  Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation.

Authors:  Mengling Wu; Qianrui Huang; Yao Xie; Xuyi Wu; Hongbo Ma; Yiwen Zhang; Yong Xia
Journal:  J Hematol Oncol       Date:  2022-03-12       Impact factor: 17.388

Review 7.  PD-1 and its ligands are important immune checkpoints in cancer.

Authors:  Yinan Dong; Qian Sun; Xinwei Zhang
Journal:  Oncotarget       Date:  2017-01-10

8.  Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response.

Authors:  Hala A Agina; Nermine A Ehsan; Taghreed A Abd-Elaziz; Ghada A Abd-Elfatah; Eman M Said; Mostafa M Sira
Journal:  Clin Exp Hepatol       Date:  2019-09-05

9.  TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

Authors:  Glen M Chew; Tsuyoshi Fujita; Gabriela M Webb; Benjamin J Burwitz; Helen L Wu; Jason S Reed; Katherine B Hammond; Kiera L Clayton; Naoto Ishii; Mohamed Abdel-Mohsen; Teri Liegler; Brooks I Mitchell; Frederick M Hecht; Mario Ostrowski; Cecilia M Shikuma; Scott G Hansen; Mark Maurer; Alan J Korman; Steven G Deeks; Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  PLoS Pathog       Date:  2016-01-07       Impact factor: 6.823

Review 10.  Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.

Authors:  Xianjie Jiang; Jie Wang; Xiangying Deng; Fang Xiong; Junshang Ge; Bo Xiang; Xu Wu; Jian Ma; Ming Zhou; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong; Can Guo; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2019-01-15       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.